Chemical structures of<unk>  components of Alzheimer<unk> s (A) CAD106 and (B) ACI-35. Cancer * Gp100<unk>  is studied to treat melanoma. To generate a greater in vitro CTL response, the<unk> , gp100:209-217(210M), is modified and binds to HLA-A2*0201. After<unk> tion, more circulating T cells can recognize and kill melanoma cancer cells in vitro. * Rindopepimut is the epidermal growth factor receptor (EGFR)-derived<unk>  to treat glioblastoma multiforme (GBM). The 14-mer<unk>  is coupled with keyhole limpet hemocyanin (KLH), which can reduce the risk of cancer. * E75, GP2, and AE37 are three different HER2/neu-derived single-peptide<unk> s to treat breast cancer. HER2/neu usually has low expression in healthy tissues. E75 consisting of 9 amino acids is the immunodominant epitope of the HER2 protein. GP2 consisting of 9 amino acids is the subdominant epitope. Both E75 and GP2 stimulate the CD8+ lymphocytes but GP2 has a lower affinity than E75. AE37 stimulates CD4+ lymphocytes. Other common diseases * EpiVacCorona, a<unk> -based<unk>  against COVID-19. * IC41 is a<unk>  candidate against the Hepatitis C virus. It consists of five synthetic<unk> s along with the synthetic adjuvant called poly-l-arginine. * Multimeric-001 is the most efficient<unk>  candidate against influenza. It contains B- and T-cell epitopes from Hemagglutinin. Matrix I and nucleoprotein are combined into a single recombinantly-expressed polypeptide. * Alzheimer<unk> s: CAD106, UB311, Lu, AF20513, ABvac40, ACI-35, AADvac-1.
Peptide vaccine
Synthetic vaccine
Conjugate vaccine
Cell-based vaccine
Subunit vaccine
Genetically modified vaccine
Genetic vaccine
Viral vector vaccine